US Patent 10494327 Controlled release pharmaceutical formulations
Patent 10494327 was granted and assigned to United Therapeutics on December, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+237 characters)
Article
Patent abstract
Disclosed herein are drug release polymer compounds and compositions comprising prostacyclin compounds of Formula (I), and methods of preparing the same. A preferred polymer has a repeating unit of the following structure:
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Peter Laing0
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 2 Aug, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
104943270
Date of Patent
December 3, 2019
0Patent Application Number
156988520
Date Filed
September 8, 2017
0Patent Primary Examiner
Edits on 30 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10494327 Controlled release pharmaceutical formulations
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10494327
Date of patent
December 3, 2019
Patent application number
15698852
Date Filed
September 8, 2017
Patent primary examiner
Find more entities like US Patent 10494327 Controlled release pharmaceutical formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
